These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8794984)

  • 1. Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol.
    Krishna R; Pandit JK
    J Pharm Pharmacol; 1996 Apr; 48(4):367-70. PubMed ID: 8794984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.
    Rao PR; Reddy MN; Ramakrishna S; Diwan PV
    Eur J Pharm Biopharm; 2003 Jul; 56(1):81-5. PubMed ID: 12837485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of propranolol following oral and transdermal administration in rabbits.
    Corbo M; Liu JC; Chien YW
    J Pharm Sci; 1990 Jul; 79(7):584-7. PubMed ID: 2398465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
    Conjeevaram R; Chaturvedula A; Betageri GV; Sunkara G; Banga AK
    Pharm Res; 2003 Sep; 20(9):1496-501. PubMed ID: 14567646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrocloride.
    Bigucci F; Abruzzo A; Cerchiara T; Gallucci MC; Luppi B
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1017-25. PubMed ID: 24918172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the in-vitro percutaneous absorption of propranolol from disperse systems.
    Ktistis G; Niopas I
    J Pharm Pharmacol; 1998 Apr; 50(4):413-8. PubMed ID: 9625486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use.
    Rao PR; Ramakrishna S; Diwan PV
    Pharm Dev Technol; 2000; 5(4):465-72. PubMed ID: 11109246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol hydrochloride-loaded liposomal gel for transdermal delivery: Characterization and in vivo evaluation.
    Guan Y; Zuo T; Chang M; Zhang F; Wei T; Shao W; Lin G
    Int J Pharm; 2015 Jun; 487(1-2):135-41. PubMed ID: 25882014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma.
    Zhou W; He S; Yang Y; Jian D; Chen X; Ding J
    Drug Dev Ind Pharm; 2015; 41(7):1109-19. PubMed ID: 25151873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride.
    Namdeo A; Jain N
    J Control Release; 2002 Aug; 82(2-3):223-36. PubMed ID: 12175739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Curr Drug Deliv; 2011 Mar; 8(2):213-24. PubMed ID: 21235472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of metoprolol. II: In-vitro skin permeation and bioavailability in hairless rats.
    Ghosh TK; Adir J; Xiang SL; Onyilofur S
    J Pharm Sci; 1995 Feb; 84(2):158-60. PubMed ID: 7738793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride.
    Cui Y; Li L; Zhang L; Li J; Gu J; Gong H; Guo P; Tong W
    Arch Pharm Res; 2011 Sep; 34(9):1477-85. PubMed ID: 21975809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
    Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
    J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal controlled delivery of propranolol from a multilaminate adhesive device.
    Corbo M; Liu JC; Chien YW
    Pharm Res; 1989 Sep; 6(9):753-8. PubMed ID: 2813272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
    Mishra D; Garg M; Dubey V; Jain S; Jain NK
    J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of mepindolol and propranolol in normal man. 1st communication: study design, clinical and pharmacodynamic aspects.
    de Mey C; Enterling D; Ederhof M; Wesche H; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1505-8. PubMed ID: 2576200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.